Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion

Head and Neck

Volumn 28, Issue 12, 2006, Pages 1142-1146

  Plasencia, Y López ^a   Cortés, M Boronat ^a   Arencibia, D Marrero ^a   Dámaso, T Montenegro ^a   Contreras, I Lisner ^a   Pino, A Ojeda ^a   Domínguez, A Carrillo ^a   Brier, F La Roche ^a   Delgado, Y García ^a   Mogollón, F J Nóvoa ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Arginine vasopressin; Intranasal tumor; Olfactory neuroblastoma; SIADH

Indexed keywords

SODIUM; VASOPRESSIN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRY NOSE; ELECTROLYTE DISTURBANCE; ESTHESIONEUROBLASTOMA; EVALUATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPONATREMIA; IMAGE ANALYSIS; INAPPROPRIATE VASOPRESSIN SECRETION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; RADIATION DOSE; SODIUM BLOOD LEVEL; SYMPTOM; VASOPRESSIN BLOOD LEVEL;

ADULT; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; INAPPROPRIATE ADH SYNDROME; NASAL CAVITY; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS;

EID: 33845331377     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20352     Document Type: Article

References (20)

1. Broich B, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumor in 1924. Anticancer Res 1997;17:2683-2706.
2. Chao KS, Kaplan C, Simpson JR, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001;23:749-757.
3. Olsen KD, Le Santo LW. Lés esthésioneuroblastoes olfactifs. Étude clinique et évolution. Arch Otolaringol 1983;109:7997-8002.
4. Girod D, Hanna E, Marentette L. Esthesioneuroblastoma. Head Neck 2001;23:500-505.
5. Anderson RJ, Chung H, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenic role of vasopressin. Ann Intern Med 1985;102:164.
6. Rose BD, Post TW. In: Clinical physiology of acid base and electrolyte disorders. 5th ed. New York: McGraw-Hill; 2001. p 699-711.
7. Freda BJ, Davidson MB, Hall PM. Evaluation of hyponatremia: a little physiology goes a long way. Cleve Clin J Med 2004;71:639-650.
8. Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 2003;35:1495-1499.
9. Verbalis JG. Inappropriate antidiuresis and other hypoosmolar states. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott Williams & Wilkins; 2001. p 297.
10. Sorensen JB, Andersen MK, Hansen HH. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 1995;238:97-110.
11. Ferlito A, Rinaldo A, Devaney KO. Syndrome of inappropriate antidiuretic hormone secretion associated with head and neck cancers: review of the literature. Ann Otol Rhinol Laryngol 1997;106:878-883.
12. Singh W, Ramage C, Best P, Angus B. Nasal neuroblastoma secreting vasopressin. Cancer 1980;45:961-966.
13. Srigley JR, Dayal VS, Gregor RT, Love R, van Nostrand AW. Hyponatremia secondary to olfactory neuroblastoma. Arch Otolaryngol 1983;109:559-562.
14. Cullen MJ, Cusack DA, O'Briain DS, Devlin JB, Kehely A, Lyons TA. Neurosecretion of AVP by an olfactory neuroblastoma causing reversible syndrome of antidiuresis. Am J Med 1986;81:911-916.
15. Osterman J, Calhoun A, Dunham M, et al. Chronic syndrome of inappropriate antidiuretic hormone secretion and hypertension in a patient with olfactory neuroblastoma. Arch Intern Med 1986;146:1731-1735.
16. Myers S, Hardy D, Wiebe C, Shiffman J. Olfactory neuroblastoma invading the oral cavity in a patient with inappropriate antidiuretic hormone secretion. Oral Surg Oral Med Oral Pathol 1994;77:645-650.
17. Al Ahwal M, Jha N, Nabhotz JM, Hugh J, Birchall I, Nguyen GK. Olfactory neuroblastoma: report of a case associated with inappropriate antidiuretic hormone secretion. J Otolaryngol 1994;23:437-439.
18. Bernard P, Vitrey D, Boursier C, Brunot J, Flechaire A. Olfactory esthesioneuroma manifesting as Schwartz-Bartter syndrome. Rev Méd Interne 2000;21:278-281.
19. Miura K, Mineta H, Yokota N, Tsutsiu Y. Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy. Pathol Int 2001;51:942-947.
20. Müller MB, Landgraf R, Keck ME. Vasopressin, major depression and hypothalamic-pituitary-adrenocortical desensitization. Biol Psychiatry 2000;48:330-333.